SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-034451
Filing Date
2024-08-30
Accepted
2024-08-29 20:54:45
Documents
21
Period of Report
2024-08-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 63514
2 ex4-1.htm EX-4.1 112560
3 ex4-2.htm EX-4.2 122513
4 ex4-3.htm EX-4.3 117868
5 ex5-1.htm EX-5.1 26129
6 ex10-1.htm EX-10.1 288414
7 ex10-2.htm EX-10.2 75646
8 ex99-1.htm EX-99.1 18710
9 ex5-1_001.jpg GRAPHIC 19335
  Complete submission text file 0001493152-24-034451.txt   1203847

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE ensc-20240829.xsd EX-101.SCH 3012
11 XBRL LABEL FILE ensc-20240829_lab.xml EX-101.LAB 34240
12 XBRL PRESENTATION FILE ensc-20240829_pre.xml EX-101.PRE 22357
23 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3741
Mailing Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037
Business Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037 (858) 263-4196
Ensysce Biosciences, Inc. (Filer) CIK: 0001716947 (see all company filings)

IRS No.: 822755287 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38306 | Film No.: 241265568
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)